NCT00329147View on ClinicalTrials.gov

Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

June 30, 2006

Conditions
Depression
Interventions
DRUG

desvenlafaxine SR

DRUG

desipramine

DRUG

paroxetine

Trial Locations (1)

07753

Neptune City

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00329147 - Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects | Biotech Hunter | Biotech Hunter